Related references
Note: Only part of the references are listed.ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy
Sambavy Nadaraja et al.
ACTA ONCOLOGICA (2020)
Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis
JinHui Liu et al.
CANCER CELL INTERNATIONAL (2019)
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients
Hui Ye et al.
BIOSCIENCE REPORTS (2019)
Identification of a novel gene pairs signature in the prognosis of gastric cancer
Pai-Lan Peng et al.
CANCER MEDICINE (2018)
Four differentially methylated gene pairs to predict the prognosis for early stage hepatocellular carcinoma patients
Shaoguang Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma
Yuan-Lei Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma
Yizi Wang et al.
CANCER MEDICINE (2018)
A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
Yanding Zhao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition
Xiaorong Luan et al.
ONCOTARGETS AND THERAPY (2017)
Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma
Mao Qixing et al.
ONCOTARGET (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer
Alisa A. Suen et al.
MOLECULAR CANCER RESEARCH (2016)
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
Wen Cheng et al.
NEUROLOGY (2016)
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
Jianjun Han et al.
GYNECOLOGIC ONCOLOGY (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Metabolic Vulnerabilities in Endometrial Cancer
Frances L. Byrne et al.
CANCER RESEARCH (2014)
Prognostic Value of a Nine-Gene Signature in Glioma Patients Based on mRNA Expression Profiling
Zhao-Shi Bao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism
Michael A. Thomas et al.
BMC GENOMICS (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
What should physicians look for in evaluating prognostic gene-expression signatures?
Jyothi Subramanian et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis
Alexandra Giatromanolaki et al.
GYNECOLOGIC ONCOLOGY (2006)
Share Paper
